Publications found:
161
Sort by:
U.S. Asthma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Anti-inflammatory, Bronchodilators), By Device Type (Inhalers, Nebulizers), By Route of Administration (Oral, Inhaled), By Product, And Segment Forecasts, 2025 - 2033
US$ 5,950.00
The U.S. asthma therapeutics market size was estimated at USD 13.00 billion in 2024 and is projected to reach USD 19.20 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The rising number...
October 2025
100 pages
Acute Respiratory Distress Syndrome (Ards) Market Outlook 2025-2034: Market Share, and Growth Analysis By Type (Diagnosis, Treatment), By Cause (COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes), By Severity, By End User
US$ 3,950.00
The Acute Respiratory Distress Syndrome (Ards) Market is valued at USD 1.8 billion in 2025 and is projected to grow at a CAGR of 10.5% to reach USD 4.4 billion by 2034.The acute respiratory distress s...
October 2025
160 pages
Chronic Obstructive Pulmonary Disease (Copd) Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Combination Therapy, Bronchodilators, Corticosteroids, Phosphodiesterase Type 4 Inhibitor, Mucokinetics, Other Drug Classes), By Type (Chronic Bronchitis, Emphysema), By End-User
US$ 3,950.00
The Chronic Obstructive Pulmonary Disease (Copd) Treatment Market is valued at USD 18.6 billion in 2025 and is projected to grow at a CAGR of 4.8% to reach USD 28.2 billion by 2034.The Chronic Obstruc...
October 2025
160 pages
Emphysema Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Treatment (Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments), By Distribution Channel (Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies), By End-User
US$ 3,950.00
The Emphysema Treatment Market is valued at USD 7 billion in 2025 and is projected to grow at a CAGR of 6.8% to reach USD 12.6 billion by 2034. Market Overview: Emphysema Treatment Market The emphysem...
October 2025
160 pages
Anti-Asthmatics And Copd Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Bronchodilators, Anti-Inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Distribution Channel (Hospital Pharmacies, General Pharmacies, Online Retailers), By End User, By Therapy, By Route Of Administration, By Age Group
US$ 3,950.00
The Anti-Asthmatics And Copd Drugs Market is valued at USD 69.6 billion in 2025 and is projected to grow at a CAGR of 6% to reach USD 117.6 billion by 2034.The Anti-Asthmatic and COPD Drugs Market foc...
October 2025
160 pages
Asthma Drugs Market Outlook 2025-2034: Market Share, and Growth Analysis By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma), By Therapy, By Drug Class, By End-User
US$ 3,950.00
The Asthma Drugs Market is valued at USD 20.9 billion in 2025 and is projected to grow at a CAGR of 4.7% to reach USD 31.5 billion by 2034. Asthma Drugs Market The asthma drugs market continues to exp...
October 2025
160 pages
Inhaled Antibiotics Market Outlook 2025-2034: Market Share, and Growth Analysis By Product Type( Aerosol or Metered Dose Inhaler, Dry Powder Formulation, Spray, Other Types), By Application( Pneumonia, Asthma, Bronchitis, Other Applications), By End-User
US$ 3,950.00
The Inhaled Antibiotics Market is valued at USD 2.1 billion in 2025 and is projected to grow at a CAGR of 7.5% to reach USD 4 billion by 2034.The inhaled antibiotics market focuses on the development...
October 2025
160 pages
Respiratory Syncytial Virus (Rsv) Therapeutics Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug (Palivizumab, Ribavirin, Other Drugs), By Treatment (Immune Prophylaxis, Supportive Care, Antiviral Medications), By Dosage Form, By Patient Type, By Distribution Channel
US$ 3,950.00
The Respiratory Syncytial Virus (Rsv) Therapeutics Market is valued at USD 2.3 billion in 2025 and is projected to grow at a CAGR of 20.7% to reach USD 12.5 billion by 2034.The Respiratory Syncytial V...
October 2025
160 pages
Severe Acute Respiratory-Syndrome Treatment Market Outlook 2025-2034: Market Share, and Growth Analysis By Drug Class (Antibiotics, Antiviral, Corticosteroids, Monoclonal Antibodies, Other Drug Classes), By Route Of Administration (Oral, Intravenous), By Indication, By Distribution Channel
US$ 3,950.00
The Severe Acute Respiratory-Syndrome Treatment Market is valued at USD 4.6 billion in 2025 and is projected to grow at a CAGR of 15.9% to reach USD 17.4 billion by 2034.The Severe Acute Respiratory S...
October 2025
160 pages
Global Pneumonia Treatment Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Pneumonia Treatment Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Pneumonia Treatment Drugs market by product type, application ...
October 2025
118 pages
Global Tuberculosis Treatment Drugs Market Growth 2025-2031
US$ 3,660.00
... the growth prospects of global Tuberculosis Treatment Drugs market for 2018-2023. This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Treatment Drugs market by product type, application ...
October 2025
102 pages
Global Alpha1-Proteinase Inhibitor Market Growth 2025-2031
US$ 3,660.00
The global Alpha1-Proteinase Inhibitor market size is predicted to grow from US$ 8677 million in 2025 to US$ 10060 million in 2031; it is expected to grow at a CAGR of 2.5% from 2025 to 2031. The impa...
October 2025
96 pages
Global Corticosteroid Nasal Spray Market Growth 2025-2031
US$ 3,660.00
The global Corticosteroid Nasal Spray market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
86 pages
Global Bronchodilators Market Growth 2025-2031
US$ 3,660.00
The global Bronchodilators market size is predicted to grow from US$ 34540 million in 2025 to US$ 45090 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. The impact of the l...
October 2025
80 pages
Global Rhinovirus Infections Drug Market Growth 2025-2031
US$ 3,660.00
The global Rhinovirus Infections Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest...
October 2025
88 pages
Global Bronchitis Drug Market Growth 2025-2031
US$ 3,660.00
The global Bronchitis Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tarif...
October 2025
103 pages
Global Erdosteine Market Growth 2025-2031
US$ 3,660.00
The global Erdosteine market size is predicted to grow from US$ 89.2 million in 2025 to US$ 117 million in 2031; it is expected to grow at a CAGR of 4.6% from 2025 to 2031. The impact of the latest U....
October 2025
76 pages
Global Bronchodilator Market Growth 2025-2031
US$ 3,660.00
The global Bronchodilator market size is predicted to grow from US$ 34540 million in 2025 to US$ 45090 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. The impact of the la...
October 2025
112 pages
Global Influenza Medication Market Growth 2025-2031
US$ 3,660.00
The global Influenza Medication market size is predicted to grow from US$ 3578 million in 2025 to US$ 5292 million in 2031; it is expected to grow at a CAGR of 6.7% from 2025 to 2031. The impact of th...
October 2025
105 pages
Global Allergic Rhinitis Drugs Market Growth 2025-2031
US$ 3,660.00
The global Allergic Rhinitis Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U....
October 2025
175 pages
Global Asthma Drugs Market Growth 2025-2031
US$ 3,660.00
The global Asthma Drugs market size is predicted to grow from US$ 241 million in 2025 to US$ 313 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031. The impact of the latest U...
October 2025
94 pages
Global Cough Medicine Market Growth 2025-2031
US$ 3,660.00
The global Cough Medicine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tariff...
October 2025
76 pages
Global Budesonide Aerosol Market Growth 2025-2031
US$ 3,660.00
The global Budesonide Aerosol market size is predicted to grow from US$ 2909 million in 2025 to US$ 12610 million in 2031; it is expected to grow at a CAGR of 27.7% from 2025 to 2031. The impact of th...
October 2025
126 pages
Global Budesonide Sprays Market Growth 2025-2031
US$ 3,660.00
The global Budesonide Sprays market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S. tar...
October 2025
128 pages
Global Cystic Fibrosis Drugs Market Growth 2025-2031
US$ 3,660.00
The global Cystic Fibrosis Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The impact of the latest U.S....
October 2025
164 pages
Global Bronchodilators Market - 2025 -2033
US$ 4,350.00
Bronchodilators Market Size & Industry Outlook The global bronchodilators market size reached US$ 23.09 Billion with rise of US$ 24.07 Billion in 2024 is expected to reach US$ 36.04 Billion by 2033, g...
October 2025
180 pages
Global Idiopathic Pulmonary Fibrosis Market - 2025 -2033
US$ 4,350.00
Idiopathic Pulmonary Fibrosis Market Size and Growth The global idiopathic pulmonary fibrosis market size reached US$ 4.24 Billion in 2024 from US$ 3.96 Billion in 2023 and is expected to reach US$ 8....
October 2025
180 pages
Global Obstructive Sleep Apnea (OSA) Market - 2025 -2033
US$ 4,350.00
Obstructive Sleep Apnea (OSA) Market Size The global obstructive sleep apnea market size reached US$ 748.11 Million in 2024 from US$ 651.19 Million in 2023 and is expected to reach US$ 2,868.50 Millio...
October 2025
180 pages
Global Erdosteine Capsules Market Growth 2025-2031
US$ 3,660.00
The global Erdosteine Capsules market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Erdosteine ??Capsules is a drug...
September 2025
75 pages
Bronchodilators Market Report by Indication (Asthma, Chronic Obstructive Pulmonary Disease (COPD), and Others), Drug Type (Sympathomimetics, Anticholinergics, Phosphodiesterase Inhibitor, Combination Drugs), Route of Administration (Oral, Injection, Inhaler), and Region 2025-2033
US$ 3,999.00
The global bronchodilators market size reached USD 39.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 57.7 Billion by 2033, exhibiting a growth rate (CAGR) of 4.15% dur...
September 2025
147 pages
Pulmonary Arterial Hypertension Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Prostacyclin and Prostacyclin Analogs, Calcium Channel Blockers, Phosphodiesterase 5, Endothelin Receptor Antagonist and Others), By Type (Branded, Generics), By Route of Administration (Oral, Intravenous/ Subcutaneous, Inhalational), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Pulmonary Arterial Hypertension Market was valued at USD 8.29 billion in 2024 and is expected to reach USD 12.00 billion in the forecast period with a CAGR of 6.32% through 203...
August 2025
188 pages
Respiratory Disease Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Test Type (Imaging Tests, Mechanical Tests, and In-vitro Diagnostic Tests), By Application (COPD, Lung Cancer, Asthma, Tuberculosis), By End User (Hospitals, Diagnostic Centers, and Others), By Region and Competition, 2020-2030F
US$ 4,500.00
Market Overview Global Respiratory Disease Testing Market was valued at USD 6.01 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 5.72% through 2030F....
August 2025
180 pages
Cystic Fibrosis Therapeutics Market Report by Drug Class (Pancreatic Enzyme Supplements, Mucolytics, Bronchodilators, CFTR Modulators, Antibiotics, and Others), Drug Molecule Type (Small Molecule Drugs, Biologics), Route of Administration (Oral Drugs, Inhaled Drugs), End-User (Hospitals, Clinics, and Others), and Region 2025-2033
US$ 3,999.00
The global cystic fibrosis therapeutics market size reached USD 7.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR)...
August 2025
119 pages
Alpha 1 Antitrypsin Deficiency Treatment Market Report by Treatment Type (Augmentation Therapy, Bronchodilators, Corticosteroids, Oxygen Therapy, and Others), Route of Administration (Parenteral, Inhalation, Oral), End User (Hospitals, Specialty Clinics, and Others), and Region 2025-2033
US$ 3,999.00
The global alpha 1 antitrypsin deficiency treatment market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.2 Billion by 2033, exhibiting a growth r...
August 2025
119 pages
Brazil Respiratory Drugs Market, By Type (Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis), By Distribution Channel (Prescription, Over-the-Counter), By End User (Hospitals, Ambulatory Care, Homecare, Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview The Brazil Respiratory Drugs Market was valued at USD 441.82 million in 2024 and is projected to reach USD 662.71 million by 2030, growing at a CAGR of 6.95%. This market represents a...
July 2025
85 pages
United States Asthma Treatment Market By Drug Class (Short-Acting Beta-Agonists (SABA), Long-Acting Beta-Agonists (LABA), Inhaled Corticosteroids (ICS), Leukotriene Modifiers, Immunomodulators, Combination Drugs, Others), By Mode of Administration (Inhalers, Nebulizers, Oral Medications), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Market Overview The United States Asthma Treatment Market was valued at USD 13.42 Billion in 2024 and is projected to reach USD 17.36 Billion by 2030, growing at a CAGR of 4.36%. This growth is fueled...
July 2025
82 pages
Metered Dose Inhalers Market By Product Type (Conventional MDIs, Breath actuated MDIs), By Application (Asthma, COPD, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2025-2034
US$ 2,655.00
The metered dose inhalers market was valued at $10,081.4 million in 2024 and is estimated to reach $18,406.27 million by 2034, exhibiting a CAGR of 6.2% from 2025 to 2034. A Metered Dose Inhaler (MDI)...
June 2025
346 pages
Global Sinusitis Treatment Market Size, Share, and Analysis, By Disease (Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis), By Age (Paediatrics, Adults), By Treatment (Surgery, Analgesics, Corticosteroids, Antihistamines, Quinolones, Antibiotics, Sulphonamides), By Route of Administration (Injectable, Nasal, Topical, Oral), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), By End User (Hospitals, Speciality Clinics, Homecare, Others) and Regional Forecasts, 2022-2032
US$ 5,150.00
Global Sinusitis Treatment Market Size, Share, and Analysis, By Disease (Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis), By Age (Paediatrics, Adults), By Treatment (Surgery, Analgesics,...
December 2023
371 pages
